Humanpharmakologisches Zentrum Biberach
Biberach/Riß, 88397, Germany
NCT Number: NCT06772532
The main objective of this trial is to investigate relative bioavailability of BI 456906 formulation B and BI 456906 formulation C vs. BI 456906 formulation A.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 1
Biberach/Riß, 88397, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Further inclusion criteria apply.
Exclusion criteria
Further exclusion criteria apply.
Formulation A
Other names: Survodutide
Formulation B
Other names: Survodutide
Formulation C
Other names: Survodutide
Time frame: Up to 22 days
Time frame: Up to 22 days
Time frame: Up to 22 days
Boehringer Ingelheim
Industry
Relative Bioavailability of Three Different BI 456906 Formulations Following Subcutaneous Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Three-period, Three-sequence Crossover Trial)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details